Magnolia Medical Technologies

Seattle, WA · Founded 2006 · Privately Held (backing)

Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. Magnolia Medical Technologies is based in Seattle, WA and was founded in 2006. It was valued at $244 million at its growth round in Jan 2025, the last priced event on record. It has raised $184 million across 6 recorded rounds; the latest was a $43.4 million early-stage round in Jan 2022.

PMV mark · valuation
$244.0M
Oct 2026
Priced at
its growth round
Jan 2025
Total raised
$183.9M
Last round
Early Stage VC
Jan 2022
What is Magnolia Medical Technologies worth?
$244.0MPrivateMarketView mark · Oct 2026

Valued at $244.0M at its growth round, Jan 2025. Nothing has traded since.

Free account
More of Magnolia Medical Technologies with a free account
  • ·The complete investor list: 22 names
  • ·Watch Magnolia Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Magnolia Medical Technologies funding history

6 rounds
DateRoundRaisedPost-money
Jan 2022Early Stage VC$43.4M▮
Dec 2018Early Stage VC$19.6M▮
Jun 2016Early Stage VC$21.0M▮
Feb 2016Debt$1.4M▮
May 2015Early Stage VC$6.2M▮
Aug 2013Seed Round$2.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Magnolia Medical Technologies valuation

Magnolia Medical Technologies was valued at $244 million at its growth round in Jan 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Magnolia Medical Technologies raised?

Magnolia Medical Technologies has raised $184 million across 6 recorded rounds since 2013. The largest was a $6.2 million early-stage round in May 2015; the most recent was a $43.4 million early-stage round in Jan 2022.

Magnolia Medical Technologies has filed 10 Form Ds with the SEC since 2011, most recently in Jan 2022 ($43.4 million sold to 18 investors).

How Magnolia Medical Technologies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Magnolia Medical Technologies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Magnolia Medical Technologies

What is Magnolia Medical Technologies worth?
Magnolia Medical Technologies is valued at $244.0M as of Oct 2026. Valued at $244.0M at its growth round, Jan 2025. Nothing has traded since.
How much has Magnolia Medical Technologies raised?
Magnolia Medical Technologies has raised $183.9M in total funding across 6 recorded rounds.
When did Magnolia Medical Technologies last raise?
Magnolia Medical Technologies last raised in Jan 2022 (Early Stage VC), raising $43.4M.